Biodegradable nanoparticles for targeted delivery in treatment of ulcerative colitis

Advanced Science Letters

Volumn 4, Issue 2, 2011, Pages 349-356

  Mahajan, Nilesh ^a   Sakarkar, Dinesh ^b   Manmode, Amit ^c   Pathak, Vinayak ^d   Ingole, Ranjit ^d   Dewade, Durgesh ^a  

^a SGSPS Institute of Pharmacy   (India)

^b Sudhakarrao Naik Institute of Pharmacy Pusad   (India)

^c Astron Research Limited   (India)

^d Maharashtra Animal and Fishery Sciences University   (India)

Author keywords

Clinical activity; Meselamine; Nanoparticles; PLGA; Ulcerative colitis

Indexed keywords

EID: 79953118155     PISSN: 19366612     EISSN: 19367317     Source Type: Journal    
DOI: 10.1166/asl.2011.1247     Document Type: Article

References (27)

1. A. Lamprecht, A. Stallmach, and Y. Kawashima, C. Drugs Future 27, 961 (2002).
2. A. Lamprecht, Current Drug Targets-Inflammation and Allergy 2, 137 (2003).
3. M. Allison, S. Cornwall, and L. Poulter, Gut. 29, 1531 (1988).
4. C. Seldenrijk, H. Drexhage, S. Meuwissen, and S. Pals, C. Meijer Gut. 30, 484 (1989).
5. Y. Tabata, Y. Inoue, and Y. Ikada, Vaccine 14, 1677 (1996).
6. J. Stein, J. Ries, and K. Barrett, Am. J. Physiol. 274, G203 (1998).
7. H. Nakase, K. Okazaki, Y. Tabata, S. Uose, and M. Ohana, J. Pharmacol. Exp. Ther. 292, 15 (2000).
8. H. Nakase, K. Okazaki, Y. Tabata, S. Uose, M. Ohana, K. Uchida, and T. Nishi, J. Pharmacol. Exp. Ther. 297, 1122 (2001).
9. A. Lamprecht, N. Ubrich, H. Yamamoto, U. Schäfer, H. Takeuchi, P. Maincent, Y. Kawashima, and C. Lehr, J. Pharmacol. Exp. Therap. 299, 775 (2001).
10. H. Tozaki, T. Fujita, J. Komoike, S. Kim, H. Terashima, S. Muranishi, S. Okabe, and A. Yamamoto, J. Pharm. Pharmacol. 51, 257 (1999).
11. F. Hardy, S. Davis, R. Khosla, and C. Robertson, Int. J. Pharm. 48, 79 (1988).
12. A. Lamprecht, U. Schäfer, and C. Lehr, Pharm. Res. 18, 788 (2001).
13. X. Y. Li, X. Li, X. Y. Kong, S. Shi, G. Guo, J. Zhang, F. Luo, X. Zhao, Y. Q. Wei, Z. Y. Qian, and L. Yang, J. Nanosci. Nanotechnol. 10, 4850 (2010).
14. H. Hosseinkhani, M. Hosseinkhani, E. V. Farahani, and M. N. Haghighi, Mehdi Nekoomanesh Adv. Sci. Lett. 2, 70 (2009).
15. K. C. Barick and D. Bahadur, J. Nanosci. Nanotechnol. 10, 668 (2010).
16. K. Ariga, J. P. Hill, M. V. Lee, A. Vinu, R. Charvet, and S. Acharya, Sci. Technol. Adv. Mater. 9, 014109 (2008).
17. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Controlled Release 25, 89 (1993).
18. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima, Int. J. Pharm. 87, 143 (1999).
19. V. Quintanar-Guerrero, E. Alle'mann, V. Fessi, and E. Doelker, Drug Dev. Ind. Pharm. 24, 1113 (1998).
20. B. MacPherson and C. Pfeiffer, Digestion 17, 136 (1978).
21. R. Ritzpatrick, J. Bostwick, M. Renzetti, R. Pendleton, and D. Decktor, Agents Actions 30, 393 (1990).
22. G. Hartmann, C. Bidlingmaier, B. Siegmund, S. Albrich, J. Schulze, K. Tschoep, A. Eigler, H. Lehr, and S. Endres, J. Pharmacol. Exp. Ther. 292, 22 (2000).
23. A. Lamprecht, N. Ubrich, H. Yamamoto, U. Schafer, H. Takeuchi, P. Maincent, Y. Kawashima, and C. Lehr, J. Pharmacol. Exp. Ther. 299, 775 (2001).
24. G. Yue, F. Sun, C. Dunn, K. Yin, and P. Wong, J. Pharmacol. Exp. Ther. 276, 265 (1996).
25. J. Krawiscz, P. Sharon, and W. Stenson, Gastroenterology 87, 1344 (1984).
26. A. Jagtap, S. Shirke, and A. Phadke, J. Ethnopharmacol. 90, 195 (2004).
27. M. Rodriguez, J. Antunez, C. Taboada, B. Seijo, and D. Torres, J. Pharm. Pharmacol. 53, 1207 (2001).